One was a case of diabetic macular oedema; another was a case of branch retinal vein occlusion-related macular oedema ... as we could not get choroidal imaging on OCT. Based on the current evidence, ...
They also will evaluate advances in imaging and current and emerging therapies for the treatment and management of retinal vein occlusion. Upon successful completion of this educational activity ...
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of EYLEA HD (aflibercept) Injection 8 mg for treating ...
The EYLEA HD results were consistent across patients with branch retinal vein occlusions, and those with central retinal or hemiretinal vein occlusions. Furthermore, in patients treated with EYLEA ...
In this Healio Video Perspective from Retina 2025, Roger A. Goldberg, MD, MBA, discusses the role of multimodal imaging in geographic atrophy in the era of complement inhibitors.Imaging confirms the ...
2d
GlobalData on MSNRegeneron’s macular oedema therapy shows promise in Phase III trialIn the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
which consists of 29 retinal parameters that measure retinal health, can be detected through routine fundus imaging scans of the back of the eye, investigators said. “Given that age and sex are ...
This connection explains why changes in your retinal vasculature can predict stroke ... medical facilities are scarce, a simple eye scan could become a lifesaving tool. The technology could ...
Accu-Time Systems, a leader in employee time tracking solutions, announces the launch of the stride80 time clock featuring Only|You Palm vein scan technology. This innovative solution sets a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results